These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 6134246

  • 1. Evidence that the regulation of growth hormone secretion is mediated predominantly by a growth hormone releasing factor.
    Willoughby JO, Koblar S, Jervois PM, Menadue MF, Oliver JR.
    Neuroendocrinology; 1983 May; 36(5):358-63. PubMed ID: 6134246
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effect of hypothalamic medial preoptic area somatostatin on growth hormone-releasing factor in the rat.
    Katakami H, Downs TR, Frohman LA.
    Endocrinology; 1988 Aug; 123(2):1103-9. PubMed ID: 2899498
    [Abstract] [Full Text] [Related]

  • 3. Somatostatin content of the median eminence in female rats with lesion-induced disruption of the inhibitory control of growth hormone secretion.
    Critchlow V, Rice RW, Abe K, Vale W.
    Endocrinology; 1978 Sep; 103(3):817-25. PubMed ID: 744118
    [Abstract] [Full Text] [Related]

  • 4. Intrahypothalamic actions of somatostatin and growth hormone releasing factor on growth hormone secretion.
    Willoughby JO, Brogan M, Kapoor R.
    Neuroendocrinology; 1989 Nov; 50(5):592-6. PubMed ID: 2575238
    [Abstract] [Full Text] [Related]

  • 5. Effects of hypothalamic periventricular lesions on pulsatile growth hormone secretion.
    Urman S, Kaler L, Critchlow V.
    Neuroendocrinology; 1985 Nov; 41(5):357-62. PubMed ID: 2865689
    [Abstract] [Full Text] [Related]

  • 6. A possible role of hypothalamic somatostatin in the maintenance of rat pituitary responsiveness to growth hormone-releasing factor.
    Soya H, Suzuki M.
    Endocrinology; 1990 Jan; 126(1):285-91. PubMed ID: 1967163
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long term elevations in plasma thyrotropin, but not growth hormone, concentrations associated with lesion-induced depletion of median eminence somatostatin.
    Urman S, Critchlow V.
    Endocrinology; 1983 Feb; 112(2):659-64. PubMed ID: 6129135
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of calcitonin-induced growth hormone (GH) suppression: roles of somatostatin and GH-releasing factor.
    Lengyel AM, Tannenbaum GS.
    Endocrinology; 1987 Apr; 120(4):1377-83. PubMed ID: 2881773
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus.
    Tannenbaum GS, McCarthy GF, Zeitler P, Beaudet A.
    Endocrinology; 1990 Nov; 127(5):2551-60. PubMed ID: 1977581
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
    Olchovsky D, Bruno JF, Wood TL, Gelato MC, Leidy JW, Gilbert JM, Berelowitz M.
    Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.